1.Rottingen, JA, Cameron, DW and Garnett, GP (2001) A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sexually Transmitted Diseases 28, 579–597.
2.Fox, J and Fidler, S (2010) Sexual transmission of HIV-1. Antiviral Research 85, 276–285.
3.Grosskurth, H et al. (2000) Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. The Lancet 355, 1981–1987.
4.Gray, RH and Wawer, MJ (2008) Reassessing the hypothesis on STI control for HIV prevention. The Lancet 371, 2064–2065.
5.Brotman, RM et al. (2010) Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. Journal of Infectious Diseases 202, 1907–1915.
6.Mertens, TE, Hayes, RJ and Smith, PG (1990) Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS (London, England) 4, 57–65.
7.Esber, A et al. (2015) Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: a systematic review and meta-analysis. Journal of Infectious Diseases. 212, 8–17.
8.Kenyon, C et al. (2013) Partner-concurrency associated with herpes simplex virus 2 infection in young South Africans. International Journal of STDs & AIDS 24, 804–812.
9.Kenyon, CR et al. (2018) Association between bacterial vaginosis and partner concurrency: a longitudinal study. Sexually Transmitted Infections 94, 75–77.
10.Buve, A et al. (2014) The vaginal microbiota and susceptibility to HIV. AIDS (London, England) 28, 2333–2344.
11.Weiss, HA et al. (2001) The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS (London, England) 15, S97–108.
12.Lewis, DA (2013) The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae. Sexually Transmitted Infections 89, iv47–iv51.
13.Kenyon, CR, Osbak, K and Vandenbruane, M (2016) What is the appropriate therapy for asymptomatic gonorrhoea in men who have sex with men? International Journal of STDs & AIDS 27, 812–813.
14.Brotman, RM et al. (2008) A longitudinal study of vaginal douching and bacterial vaginosis‚ a marginal structural modeling analysis. American Journal of Epidemiol 168, 188–196.
15.Klebanoff, MA et al. (2004) Vulvovaginal symptoms in women with bacterial vaginosis. Obstetrics & Gynecology 104, 267–272.
16.Nugent, RP, Krohn, MA and Hillier, SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology 29, 297–301.
17.Brotman, RM (2011) Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. Journal of Clinical Investigation 121, 4610–4617.
18.Bradshaw, CS et al. (2013) Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clinical Infectious Diseases 56, 777–786.
19.Workowski, KA (2000) The 1998 CDC sexually transmitted diseases treatment guidelines. Current Infectious Diseases Report 2, 44–50.
20.Potterat, JJ et al. (1999) Chlamydia transmission: concurrency, reproduction number, and the epidemic trajectory. American Journal of Epidemiology 150, 1331–1339.
21.Ghani, AC, Swinton, J and Garnett, GP (1997) The role of sexual partnership networks in the epidemiology of gonorrhea. Sexually Transmitted Diseases 24, 45–56.
22.Kenyon, CR et al. (2016) Partner concurrency and HIV infection risk in South Africa. International Journal of Infectious Diseases 45, 81–87.
23.Kenyon, CR et al. (2017) Incident Trichomonas vaginalis is associated with partnership concurrency: a longitudinal cohort study. Sexually Transmitted Diseases 44, 695–699.
24.Horner, PJ et al. (2016) 2016 European guideline on the management of non-gonococcal urethritis. International Journal of STD & AIDS 11, 928–937.
25.Workowski, KA and Bolan, GA (2015) Sexually transmitted diseases treatment guidelines (2015). Reproductive Endocrinology, 24, 51–56.
26.Ravel, J et al. (2013) Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 1, 29.
27.Helleringer, S, Mkandawire, J and Kohler, HP (2014) A new approach to measuring partnership concurrency and its association with HIV risk in couples. AIDS and Behavior 18, 2291–2301.
28.Drumright, LN, Gorbach, PM and Holmes, KK (2004) Do people really know their sex partners? Concurrency, knowledge of partner behavior, and sexually transmitted infections within partnerships. Sexually Transmitted Diseases 31, 437–442.
29.Kenyon, CR and Hamilton, DT (2016) Correlation between Trichomonas vaginalis and concurrency: an ecological study. Interdisciplinary Perspective on Infectious Diseases 2016, 5052802.
30.Morris, M et al. (2009) Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. American Jounral of Public Health 99, 1023–1031.
31.Kenyon, C, Osbak, K and Buyze, J. The prevalence of HIV by ethnic group is correlated with HSV-2 and syphilis prevalence in Kenya, South Africa, the United Kingdom and the United States. Interdisciplinary Perspectives on Infectious Diseases 2014: Article ID 284317.